About the Business Advancement Center for Health
BACH is a Carlson School of Management center focused on reimagining health and healthcare. Through designing and evaluating innovative next-generation business models, BACH will innovate evidence-based and data-driven sustainable solutions that effectively address critical gaps in healthcare cost, access, safety and equity. Key subject areas to be explored include, but are not limited to: value-based reimbursement and payment models, investment in social well-being of individuals, organizational structures; and quality innovation.
Participatory research projects will engage the community and industry along with faculty and students to co-create novel business-driven innovations. Roundtables and consortia with industry and community partners; conferences, multi-sector forums, and interdisciplinary student competitions will emphasize collaborative work among all stakeholders.
This ecosystem will complement coursework offered at the Carlson School, expose students to state-of-the art thinking, and engage faculty in innovative real-world solutions in the health sector. Through interdisciplinary engagement with community, industry, and academia, BACH aligns sectors of the health economy to co-create business innovations and novel solutions to drive marketplace implementation.
Vision: Create a healthcare system that delivers equitable care to all individuals.
Mission: Design business-driven innovations that address gaps in health equity and improve value in healthcare through convening academia, industry and community stakeholders.
MBA-MHA, Class of 2024
The Business Advancement Center for Health (BACH) was founded in January 2022 by Professor Pinar Karaca-Mandic with a focus on creating a healthcare system that delivers equitable care to all individuals. BACH strives to design business-driven innovations that address gaps in health equity and improve value in healthcare.
Karaca-Mandic brings a wealth of healthcare marketplace expertise. As a health economist, her research has made contributions to the literature in four key areas to understand: 1) value and diffusion of medical technologies; 2) uptake of clinical guidelines and response to evidence on safety and effectiveness; 3) access and affordability of healthcare and role of the health insurance marketplace; 4) assessing competition, frictions and its impact in quality and costs.